Related Experiment Video
Updated: Dec 20, 2025
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
14.2K
How Do I Reverse Oral and Parenteral Anticoagulants?
Jürgen Koscielny1, Edita Rutkauskaite1, Christoph Sucker2
1Charité, Universitätsmedizin Berlin, Gerinnungsambulanz mit Hämophiliezentrum im Ambulanten, Gesundheitszentrum (AGZ), Berlin, Germany.
Hamostaseologie
|May 27, 2020
Summary
Understanding drug-specific reversal strategies is crucial for managing bleeding or procedures in patients on anticoagulants. This includes vitamin K, protamine, idarucizumab, andexanet alfa, and prothrombin complex concentrate (PCC).
Area of Science:
- Pharmacology
- Hematology
- Critical Care Medicine
Background:
- Anticoagulant therapy is increasingly diverse, necessitating specialized knowledge for managing bleeding complications.
- Safe patient care requires understanding specific reversal agents for various anticoagulants.
Purpose of the Study:
- To review and highlight essential drug-specific reversal strategies for anticoagulants.
- To emphasize the importance of comprehensive management beyond hemostatic treatment.
Main Methods:
- Literature review of current reversal agents and their mechanisms.
- Discussion of indications and efficacy of specific antidotes.
- Emphasis on adjunctive management strategies for bleeding events.
Main Results:
- Vitamin K reverses vitamin K antagonists (VKAs); prothrombin complex concentrate (PCC) may be needed for major VKA bleeding.
- Protamine reverses unfractionated heparin and partially low-molecular-weight heparin.
- Idarucizumab and andexanet alfa are approved for specific direct oral anticoagulants; PCC shows potential for FXa inhibitor reversal.
Conclusions:
- Drug-specific reversal agents are essential for managing bleeding and procedures in patients on anticoagulation.
- Comprehensive patient management, including supportive care and timely resumption of anticoagulation, is critical for successful outcomes.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:29Venous Thrombosis III: Interprofessional Care
205
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
205
01:24Factors Influencing Drug Absorption: Presystemic Elimination
721
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
721
01:25Routes of Drug Administration: Parenteral
2.7K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.7K
01:14Prevention of Further Absorption of Poison
1.1K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K